6-chloro-5-(2-propenyl)-uracil

enhances growth inhibition and differentiation of myeloid leukemia cells; structure in first source

Also Known As:

TI90

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Myeloid Leukemia (Leukemia, Myelocytic) 03/01/1998 - "The novel uracil analog, 6-chloro-5-(2-propenyl)uracil (TI90), inhibited the growth of myeloid leukemia cells and induced morphologic and functional differentiation of the cells. "
2.	Leukemia 03/01/1998 - "Although TI90 was a weak inducer of differentiation, it greatly enhanced the growth inhibition and differentiation of the leukemia cells previously induced by 1alpha,25-dihydroxyvitamin D3 (VD3) or all-trans retinoic acid (ATRA). "